N. Oliver

发表

Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial.

C. Toumazou, A. Majeed, Ambady Ramachandran, 2013, The lancet. Diabetes & endocrinology.

A coordinated control strategy for insulin and glucagon delivery in type 1 diabetes

Pantelis Georgiou, Jorge Bondia, Pau Herrero, 2017, Computer methods in biomechanics and biomedical engineering.

Pharmacological aspects of closed loop insulin delivery for type 1 diabetes.

N. Oliver, Chukwuma Uduku, 2017, Current opinion in pharmacology.

Case-Based Reasoning for Insulin Bolus Advice

Christofer Toumazou, Pantelis Georgiou, Pau Herrero, 2017, Journal of diabetes science and technology.

Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups.

Pratik Choudhary, J. Levy, P. Hindmarsh, 2011, Diabetes technology & therapeutics.

Artificial Pancreas: Current Progress and Future Outlook in the Treatment of Type 1 Diabetes

Monika Reddy, Nick Oliver, N. Oliver, 2019, Drugs.

Future artificial pancreas technology for type 1 diabetes: what do users want?

E. Dassau, K. Barnard, N. Oliver, 2015, Diabetes technology & therapeutics.

Response to Comment on Misra et al. Homozygous Hypomorphic HNF1A Alleles Are a Novel Cause of Young-Onset Diabetes and Result in Sulfonylurea-Sensitive Diabetes. Diabetes Care 2020;43:909–912

S. Ellard, N. Oliver, A. Gloyn, 2020, Diabetes Care.

Fasting plasma glucose and variation in cardiometabolic risk factors in people with high-risk HbA1c-defined prediabetes: A cross-sectional multiethnic study.

C. Snehalatha, I. Godsland, N. Oliver, 2017, Diabetes research and clinical practice.

Homozygous Hypomorphic HNF1A Alleles Are a Novel Cause of Young-Onset Diabetes and Result in Sulfonylurea-Sensitive Diabetes

S. Ellard, N. Oliver, A. Gloyn, 2020, Diabetes Care.

South Asian individuals with diabetes who are referred for MODY testing in the UK have a lower mutation pick-up rate than white European people

B. Shields, A. Hattersley, S. Ellard, 2016, Diabetologia.

Changes in northern hemisphere male international rugby union players’ body mass and height between 1955 and 2015

D. Amiras, N. Oliver, M. Stacey, 2018, BMJ Open Sport & Exercise Medicine.

The James Lind Alliance Research Priorities for Diabetes revisited

N. Oliver, R. Holt, 2020, Diabetic medicine : a journal of the British Diabetic Association.

Open source automated insulin delivery: addressing the challenge.

L. Heinemann, N. Oliver, M. Reddy, 2019, NPJ digital medicine.

Loss of association between HbA1c and vascular disease in older adults with type 1 diabetes

I. Godsland, N. Oliver, N. Hill, 2020, PloS one.

Enhancing self-management in type 1 diabetes with wearables and deep learning

P. Georgiou, N. Oliver, P. Herrero, 2022, npj Digital Medicine.

Relationship between islet autoantibody status and the clinical characteristics of children and adults with incident type 1 diabetes in a UK cohort

P. Bingley, D. Dunger, I. Godsland, 2018, BMJ Open.

Rationale and protocol for the After Diabetes Diagnosis REsearch Support System (ADDRESS): an incident and high risk type 1 diabetes UK cohort study

P. Bingley, D. Dunger, I. Godsland, 2017, BMJ Open.

International Society for Pediatric and Adolescent Diabetes (ISPAD)

Louisa, Aaron J. Kowalski, B. Buckingham, 2006 .

Biochemical, Physiological and Psychological Changes During Endurance Exercise in People With Type 1 Diabetes

I. Godsland, N. Oliver, P. Buchanan, 2017, Journal of diabetes science and technology.

A randomized controlled trial: the effect of inulin on weight management and ectopic fat in subjects with prediabetes

Jimmy D Bell, Elizabeth Louise Thomas, N. Oliver, 2015, Nutrition & Metabolism.

Individual and diabetes presentation characteristics associated with partial remission status in children and adults evaluated up to 12 months following diagnosis of type 1 diabetes: an ADDRESS-2 (After Diagnosis Diabetes Research Support System-2) Study Analysis.

I. Godsland, N. Oliver, D. Johnston, 2019, Diabetes research and clinical practice.

Experience of point-of-care HbA1c testing in the English National Health Service Diabetes Prevention Programme: an observational study

K. Khunti, M. Bachmann, N. Wareham, 2020, BMJ Open Diabetes Research & Care.

The use of POCT HbA1c devices in the NHS Diabetes Prevention Programme:Recommendations from an expert working group commissioned by NHS England

N. Oliver, E. English, W. G. John, 2016 .

Diabetic ketoacidosis in adults

N. Oliver, S. Misra, 2015, BMJ : British Medical Journal.

Cardiometabolic risk factors in Thai individuals with prediabetes treated in a high‐risk, prevention clinic: Unexpected relationship between high‐density lipoprotein cholesterol and glycemia in men

I. Godsland, N. Oliver, K. Alberti, 2018, Journal of diabetes investigation.

Roux-en-Y gastric bypass increases glycaemic variability and time in hypoglycaemia in patients with obesity and pre-diabetes/type 2 diabetes mellitus: a prospective cohort study

N. Oliver, S. Purkayastha, B. Khoo, 2020 .

Rationale and protocol for the Assessment of Impact of Real-time Continuous Glucose Monitoring on people presenting with severe Hypoglycaemia (AIR-CGM) study

N. Oliver, R. Fothergill, M. Reddy, 2019, BMC Endocrine Disorders.

Updated Software for Automated assessment of glucose variability and quality of glycemic control in diabetes.

N. Oliver, M. Giménez, Vanessa Moscardó, 2020, Diabetes technology & therapeutics.

Hyperglycemia recognised in early pregnancy is phenotypically type 2 diabetes mellitus not gestational diabetes mellitus: a case control study

I. Godsland, N. Oliver, J. Terry, 2020, Journal of Maternal-Fetal & Neonatal Medicine.

REPOSE: repositioning insulin pump therapy in Type 1 diabetes

N. Oliver, 2017, Diabetic medicine : a journal of the British Diabetic Association.

Glycemic Tracking Before and After Insulin Pump Initiation

I. Godsland, N. Oliver, N. Hill, 2020, Journal of diabetes science and technology.

Improved glycaemia during the Covid-19 pandemic lockdown is sustained post-lockdown and during the “Eat Out to Help Out” Government Scheme, in adults with Type 1 diabetes in the United Kingdom

I. Godsland, N. Oliver, Chukwuma Uduku, 2021, PloS one.

Assessment of Glycemic Variability in Continuous Subcutaneous Insulin Infusion Therapy in Type 1 Diabetes Related to Anthropometry and Complication Status

N. Oliver, A. Dornhorst, E. Hatfield, 2009, Journal of diabetes science and technology.

Prevention and Management Strategies for Diabetic Neuropathy

A. Davies, N. Oliver, P. Normahani, 2022, Life.

The impact of socio‐economic deprivation on access to diabetes technology in adults with type 1 diabetes

N. Oliver, M. Reddy, P. Avari, 2022, Diabetic medicine : a journal of the British Diabetic Association.

Managing diabetes at high altitude: personal experience with support from a Multidisciplinary Physical Activity and Diabetes Clinic

N. Oliver, S. Sivasubramaniyam, S. Chew, 2017, BMJ Open Sport & Exercise Medicine.

Evolving type 1 diabetes in distinguishing between type 1 and type 2 diabetes

N. Oliver, N. Hill, 2020, BMJ.

Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta‐analysis of randomised controlled trials

N. Oliver, B. Galland, B. Wheeler, 2022, Diabetic medicine : a journal of the British Diabetic Association.

Relationship between daytime vs nighttime continuous glucose monitoring metrics with A1C in Adults with Type 1 Diabetes.

D. Klonoff, N. Oliver, L. Pyle, 2022, Diabetes technology & therapeutics.

Automated Insulin Delivery Systems: Today, Tomorrow and User Requirements

N. Oliver, I. Conget, M. Giménez, 2021, Journal of diabetes science and technology.

Differences for Percentage Times in Glycaemic Range Between Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring in Adults with Type 1 Diabetes: Analysis of the REPLACE-BG Dataset.

N. Oliver, P. Herrero, Chukwuma Uduku, 2020, Diabetes technology & therapeutics.

Full Mortality risk in patients with adrenal insufficiency using Prednisolone or Hydrocortisone: A Retrospective Cohort study.

A. Majeed, I. Godsland, N. Oliver, 2021, The Journal of clinical endocrinology and metabolism.

Increased mortality risk in patients with primary and secondary adrenal insufficiency.

A. Majeed, I. Godsland, N. Oliver, 2021, The Journal of clinical endocrinology and metabolism.

Cardiovascular disease in patients with primary and secondary adrenal insufficiency and the role of comorbidities.

A. Majeed, I. Godsland, N. Oliver, 2021, The Journal of clinical endocrinology and metabolism.

Variations in access to and reimbursement for continuous glucose monitoring systems for people living with Type 1 diabetes across England

N. Oliver, E. Wilmot, N. Oliver, 2018, Diabetic medicine : a journal of the British Diabetic Association.

Continuous Glucose Monitoring Adoption in the United Kingdom — An Economic and Policy Perspective

N. Oliver, 2017, European endocrinology.

Nutritional support for a person with type 1 diabetes undertaking endurance swimming

N. Oliver, N. Hill, S. Rilstone, 2022, Frontiers in Endocrinology.

New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the U.K.

N. Oliver, S. Yeung, K. Logan, 2020, Diabetes Care.

The James Lind Alliance research priorities for diabetes

N. Oliver, R. Holt, 2019, Diabetic medicine : a journal of the British Diabetic Association.

Towards a Physiological Prandial Insulin Profile: Enhancement of Subcutaneously Injected Prandial Insulin Using Local Warming Devices

N. Oliver, A. El-Laboudi, 2015, Diabetes Therapy.

Self-monitoring of Blood Glucose Requirements with the Use of Intermittently Scanned Continuous Glucose Monitoring.

N. Oliver, M. Reddy, 2019, Diabetes technology & therapeutics.

Intentional Large Insulin Overdose Captured on a Continuous Glucose Monitor

N. Oliver, P. Deol, S. Misra, 2015, Journal of diabetes science and technology.

A Pilot Study of Flat and Circadian Insulin Infusion Rates in Continuous Subcutaneous Insulin Infusion (CSII) in Adults with Type 1 Diabetes (FIRST1D)

N. Oliver, M. Reddy, S. Rilstone, 2020, Journal of diabetes science and technology.

Glycemic Index, Extended Bolusing, and Diabetes Education in Insulin Pump Therapy (GLIDE: A Pilot Study).

N. Oliver, M. Reddy, S. Rilstone, 2019, Diabetes technology & therapeutics.

A Bio-Inspired Glucose Controller Based on Pancreatic β-Cell Physiology

Christofer Toumazou, Pantelis Georgiou, Pau Herrero, 2012, Journal of diabetes science and technology.

A Benchtop Closed-loop System Controlled by a Bio-Inspired Silicon Implementation of the Pancreatic β Cell

C. Toumazou, P. Georgiou, N. Oliver, 2009, Journal of diabetes science and technology.

Hyperinsulinemic hypoglycemia in children and adolescents: Recent advances in understanding of pathophysiology and management

M. Dattani, N. Oliver, S. Flanagan, 2020, Reviews in Endocrine and Metabolic Disorders.

Optimizing type 1 diabetes after multiple daily injections and capillary blood monitoring: Pump or sensor first? A meta‐analysis using pooled differences in outcome measures

I. Godsland, N. Oliver, A. M. Lett, 2021, Diabetes, obesity & metabolism.

Covid-19 and Diabetes: A Complex Bidirectional Relationship

G. Rutter, N. Oliver, V. Salem, 2020, Frontiers in Endocrinology.

Use of microneedle array devices for continuous glucose monitoring: a review.

N. Oliver, A. Cass, D. Johnston, 2013, Diabetes technology & therapeutics.

Is it possible to constantly and accurately monitor blood sugar levels, in people with Type 1 diabetes, with a discrete device (non‐invasive or invasive)?

N. Oliver, M. Reddy, P. Avari, 2020, Diabetic medicine : a journal of the British Diabetic Association.

A pilot study in humans of microneedle sensor arrays for continuous glucose monitoring

Pantelis Georgiou, Monika Reddy, Nick Oliver, 2018 .

A pragmatic and scalable strategy using mobile technology to promote sustained lifestyle changes to prevent type 2 diabetes in India and the UK: a randomised controlled trial

A. Darzi, A. Majeed, S. Sharp, 2020, Diabetologia.

Increasing glycaemia is associated with a significant decline in HDL cholesterol in women with prediabetes in two national populations

I. Godsland, N. Oliver, D. Johnston, 2021, Scientific Reports.

Elevated Lactate Levels in Patients With Poorly Regulated Type 1 Diabetes and Glycogenic Hepatopathy: A New Feature of Mauriac Syndrome

E. Wisse, N. Oliver, H. Bilo, 2015, Diabetes Care.

A Modular Safety System for an Insulin Dose Recommender: A Feasibility Study

Chengyuan Liu, Pantelis Georgiou, Pau Herrero, 2019, Journal of diabetes science and technology.

DR15-DQ6 remains dominantly protective against type 1 diabetes throughout the first five decades of life

M. Weedon, W. Hagopian, N. Oliver, 2021, Diabetologia.

Islet Autoantibody Level Distribution in Type 1 Diabetes and Their Association With Genetic and Clinical Characteristics

B. Shields, N. Oliver, D. Johnston, 2021, medRxiv.

Glucose management for exercise using continuous glucose monitoring: should sex and prandial state be additional considerations? Reply to Yardley JE and Sigal RJ [letter]

C. de Beaufort, Aaron J. Kowalski, B. Buckingham, 2021, Diabetologia.

Clinical Safety and Feasibility of the Advanced Bolus Calculator for Type 1 Diabetes Based on Case-Based Reasoning: A 6-Week Nonrandomized Single-Arm Pilot Study.

C. Toumazou, P. Georgiou, N. Oliver, 2016, Diabetes technology & therapeutics.

Psychosocial assessment of artificial pancreas (AP): commentary and review of existing measures and their applicability in AP research.

Nick Oliver, Korey K. Hood, K. Barnard, 2015, Diabetes technology & therapeutics.

Adverse outcomes in COVID-19 and diabetes: a retrospective cohort study from three London teaching hospitals

N. Oliver, W. Distaso, C. Izzi-Engbeaya, 2021, BMJ Open Diabetes Research & Care.

Severe COVID-19 and Diabetes: A Retrospective Cohort Study from Three London Teaching Hospitals

N. Oliver, W. Distaso, C. Izzi-Engbeaya, 2020, medRxiv.

Metabolic health and vascular complications in type 1 diabetes.

I. Godsland, N. Oliver, D. Johnston, 2019, Journal of diabetes and its complications.

Automatic Adaptation of Basal Insulin Using Sensor-Augmented Pump Therapy

Pantelis Georgiou, Jorge Bondia, Pau Herrero, 2018, Journal of diabetes science and technology.

Enhancing automatic closed-loop glucose control in type 1 diabetes with an adaptive meal bolus calculator - in silico evaluation under intra-day variability

Christofer Toumazou, Pantelis Georgiou, Jorge Bondia, 2017, Comput. Methods Programs Biomed..

Automatic Adjustment of Basal Insulin Infusion Rates in Type 1 Diabetes using Run-to-Run Control and Case-Based Reasoning

P. Georgiou, N. Oliver, P. Herrero, 2017 .

Advanced Insulin Bolus Advisor Based on Run-To-Run Control and Case-Based Reasoning

Christofer Toumazou, Pantelis Georgiou, Nick Oliver, 2015, IEEE Journal of Biomedical and Health Informatics.

Validation and regulation of point of care devices for medical applications

G. Hanna, N. Oliver, J. Huddy, 2017 .

Emerging technologies for diabetes

N. Oliver, E. D. Kennedy, 2017 .

An Economic Evaluation of Continuous Glucose Monitoring for People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia within North West London Clinical Commissioning Groups in England

N. Oliver, C. Graham, Shraddha S Chaugule, 2017, European endocrinology.

Testosterone therapy for sexual dysfunction in men with Type 2 diabetes: a systematic review and meta‐analysis of randomized controlled trials

N. Oliver, W. Dhillo, N. Oliver, 2018, Diabetic medicine : a journal of the British Diabetic Association.

Skinfold thickness measurements and mortality in white males during 27.7 years of follow-up

I. Godsland, N. Oliver, D. Johnston, 2018, International Journal of Obesity.

Type 1 diabetes in adults: supporting self management

Monika Reddy, N. Oliver, M. Reddy, 2016, British Medical Journal.

A novel hand-held interface supporting the self-management of Type 1 diabetes

Pantelis Georgiou, Robert Spence, Kezhi Li, 2020, ArXiv.

Glycemic Variability and Hypoglycemic Excursions With Continuous Glucose Monitoring Compared to Intermittently Scanned Continuous Glucose Monitoring in Adults With Highest Risk Type 1 Diabetes

N. Oliver, Vanessa Moscardó, M. Reddy, 2020, Journal of diabetes science and technology.

Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis

N. Oliver, D. Francis, A. Roddick, 2018, JAMA.

Gestational diabetes mellitus: does an effective prevention strategy exist?

N. Oliver, D. Johnston, S. Robinson, 2016, Nature Reviews Endocrinology.

Evaluation of the Accuracy of Current Tubeless Pumps for Continuous Subcutaneous Insulin Infusion

N. Oliver, G. Freckmann, D. Waldenmaier, 2020, Diabetes technology & therapeutics.

A Randomised Crossover Trial: Exploring the Dose-Response effect Of Carbohydrate restriction on glycaemia in people with well-controlled type 2 diabetes (D-ROC2): Summary.

N. Oliver, M. Abdul-Ghani, N. Guess, 2022, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

Establishing the multidisciplinary Imperial Physical Activity and Diabetes clinic

D. Amiras, N. Oliver, S. Chew, 2018 .

An In Silico Head-to-Head Comparison of the Do-It-Yourself Artificial Pancreas Loop and Bio-Inspired Artificial Pancreas Control Algorithms

P. Georgiou, N. Oliver, P. Herrero, 2021, Journal of diabetes science and technology.

Predicting Quality of Overnight Glycaemic Control in Type 1 Diabetes Using Binary Classifiers

Pantelis Georgiou, Nick Oliver, Pau Herrero, 2020, IEEE Journal of Biomedical and Health Informatics.

The Bio-inspired Artificial Pancreas for Type 1 Diabetes Control in the Home: System Architecture and Preliminary Results

Pantelis Georgiou, Pau Herrero, Monika Reddy, 2019, Journal of diabetes science and technology.

Comment on Doyle et al. Closed-Loop Artificial Pancreas Systems: Engineering the Algorithms. Diabetes Care 2014;37:1191–1197

R. Hovorka, K. Barnard, N. Oliver, 2014, Diabetes Care.

Robust set‐membership parameter estimation of the glucose minimal model

Christofer Toumazou, Luc Jaulin, Pantelis Georgiou, 2016 .

A Simple Robust Method for Estimating the Glucose Rate of Appearance from Mixed Meals

Christofer Toumazou, Josep Vehí, Pantelis Georgiou, 2012, Journal of diabetes science and technology.

An Advanced Bolus Calculator for Type 1 Diabetes: System Architecture and Usability Results

Christofer Toumazou, Pantelis Georgiou, Nick Oliver, 2016, IEEE Journal of Biomedical and Health Informatics.

A Randomised Crossover Trial: The Effect of Inulin on Glucose Homeostasis in Subtypes of Prediabetes

N. Oliver, G. Frost, A. Dornhorst, 2015, Annals of Nutrition and Metabolism.

A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia

N. Oliver, M. Reddy, N. Jugnee, 2017, Diabetic medicine : a journal of the British Diabetic Association.

Safety and feasibility of the PEPPER adaptive bolus advisor and safety system; a randomized control study.

N. Oliver, P. Herrero, J. Fernández-Real, 2020, Diabetes technology & therapeutics.

Type 2 diabetes mellitus and microvascular complications 1 year after Roux-en-Y gastric bypass: a case–control study

A. Nicotra, N. Oliver, C. L. le Roux, 2015, Diabetologia.

HbA1c: an old friend in new clothes

N. Oliver, A. Dornhorst, K. Meeran, 2011, The Lancet.

Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study

N. Oliver, M. Reddy, N. Jugnee, 2018, Diabetes technology & therapeutics.

Assessment of Glucose Control Metrics by Discriminant Ratio.

P. Georgiou, N. Oliver, P. Herrero, 2020, Diabetes technology & therapeutics.

Open source automated insulin delivery: addressing the challenge

L. Heinemann, N. Oliver, M. Reddy, 2019, npj Digital Medicine.

Cross‐sectional analysis of emergency hypoglycaemia and outcome predictors among people with diabetes in an urban population

I. Godsland, N. Oliver, Chukwuma Uduku, 2021, Diabetic medicine : a journal of the British Diabetic Association.

Feasibility study of a bio-inspired artificial pancreas in adults with type 1 diabetes.

Christofer Toumazou, Pantelis Georgiou, Pau Herrero, 2014, Diabetes technology & therapeutics.

Clinical impact of CGM use

N. Oliver, Chukwuma Uduku, M. Reddy, 2020 .

Robust determination of the optimal continuous glucose monitoring length of intervention to evaluate long-term glycaemic control.

P. Georgiou, N. Oliver, P. Herrero, 2020, Diabetes Technology & Therapeutics.

Impact of Different Types of Data Loss on Optimal Continuous Glucose Monitoring Sampling Duration.

N. Oliver, P. Herrero, J. Snell-Bergeon, 2022, Diabetes technology & therapeutics.

The post-trial analysis of the Indian SMS diabetes prevention study shows persistent beneficial effects of lifestyle intervention.

Ambady Ramachandran, C. Snehalatha, J. Ram, 2018, Diabetes research and clinical practice.

The absence of islet autoantibodies in clinically diagnosed older-adult onset type 1 diabetes suggests an alternative pathology, advocating for routine testing in this age group.

M. Weedon, A. Hattersley, N. Oliver, 2021, medRxiv.

A Composite Model of Glucagon-Glucose Dynamics for In Silico Testing of Bihormonal Glucose Controllers

Christofer Toumazou, Pantelis Georgiou, Nick Oliver, 2013, Journal of diabetes science and technology.

Robust Fault Detection System for Insulin Pump Therapy Using Continuous Glucose Monitoring

Josep Vehí, Pantelis Georgiou, Remei Calm, 2012, Journal of diabetes science and technology.

Keeping score

N. Oliver, 2021, Diabetic Medicine.

Revisiting the Relationships Between Measures of Glycemic Control and Hypoglycemia in Continuous Glucose Monitoring Data Sets

N. Oliver, I. Conget, M. Giménez, 2017, Diabetes Care.

Continuous Glucose Monitoring at High Altitude—Effects on Glucose Homeostasis

N. Oliver, K. Deighton, A. Mellor, 2018, Medicine and science in sports and exercise.

Low glycaemic variability in subjects with Type 2 diabetes following pre‐Ramadan assessment and adjustments for fasting

N. Oliver, E. Hui, 2012, Diabetic medicine : a journal of the British Diabetic Association.

Metabolic Control With the Bio-inspired Artificial Pancreas in Adults With Type 1 Diabetes

Christofer Toumazou, Pantelis Georgiou, Pau Herrero, 2016, Journal of diabetes science and technology.

Protocol for a clinical trial of text messaging in addition to standard care versus standard care alone in prevention of type 2 diabetes through lifestyle modification in India and the UK

A. Darzi, A. Majeed, S. Sharp, 2018, BMC Endocrine Disorders.

The Accuracy of Continuous Glucose Sensors in People with Diabetes Undergoing Haemodialysis (ALPHA Study).

N. Oliver, M. Reddy, P. Avari, 2023, Diabetes technology & therapeutics.

Is iatrogenic sleep disturbance worth the effort in Type 1 diabetes?

N. Oliver, D. Kerr, P. Adolfsson, 2015, Diabetic medicine : a journal of the British Diabetic Association.

Continuous Glucose Monitoring in People With Type 1 Diabetes on Multiple-Dose Injection Therapy: The Relationship Between Glycemic Control and Hypoglycemia

P. Calhoun, L. Heinemann, N. Oliver, 2019, Diabetes Care.

Minimally Invasive Enzyme Microprobes: An Alternative Approach for Continuous Glucose Monitoring

Kostis Michelakis, Nick Oliver, Jakub Trzebinski, 2012, Journal of diabetes science and technology.

Long-Term Glucose Forecasting Using a Physiological Model and Deconvolution of the Continuous Glucose Monitoring Signal

Chengyuan Liu, Josep Vehí, Pantelis Georgiou, 2019, Sensors.

Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study

N. Oliver, M. Reddy, N. Jugnee, 2018, Diabetes technology & therapeutics.

Wireless solutions for managing diabetes: A review and future prospects.

Esko Alasaarela, N. Oliver, E. Alasaarela, 2009, Technology and health care : official journal of the European Society for Engineering and Medicine.

Development and Validation of Binary Classifiers to Predict Nocturnal Hypoglycemia in Adults With Type 1 Diabetes.

P. Georgiou, N. Oliver, P. Herrero, 2023, Journal of diabetes science and technology.

A Portable Low-Power Platform for Ambulatory Closed Loop Control of Blood Glucose in Type 1 Diabetes

Mohamed El-Sharkawy, Pantelis Georgiou, Nick Oliver, 2018, 2018 IEEE International Symposium on Circuits and Systems (ISCAS).

Psychosocial assessment of artificial pancreas (AP): commentary and review of existing measures and their applicability in AP research.

K. Barnard, N. Oliver, J. Weissberg-Benchell, 2015, Diabetes technology & therapeutics.

Comment on Doyle et al. Closed-Loop Artificial Pancreas Systems: Engineering the Algorithms. Diabetes Care 2014;37:1191–1197

R. Hovorka, K. Barnard, N. Oliver, 2014, Diabetes Care.

Towards targeted dietary support for shift workers with type 2 diabetes (Shift‐Diabetes study): A mixed‐methods case study protocol

N. Oliver, R. Gibson, C. Vetter, 2021, Diabetic medicine : a journal of the British Diabetic Association.

University of Birmingham Relationship between islet autoantibody status and the clinical characteristics of children and adults with incident type 1 diabetes in a UK cohort

P. Bingley, D. Dunger, I. Godsland, 2018 .

Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring.

Ian F Godsland, I. Godsland, N. Oliver, 2016, Diabetes technology & therapeutics.